TuHURA Biosciences, Inc.
HURA · NASDAQ
9/30/2025 | 6/30/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $110 | $99 | $173 | $15 |
| - Cash | $0 | $9 | $13 | $3 |
| + Debt | $0 | $1 | $0 | $0 |
| Enterprise Value | $110 | $91 | $161 | $12 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$10 | -$5 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$23 | -$10 | -$6 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | 0 | -0.214 | -0.142 | -3 |
| % Growth | 100% | -50.9% | 95.3% | – |
| Operating Cash Flow | – | -$11 | -$3 | -$2 |
| Capital Expenditures | – | -$0 | -$0 | $0 |
| Free Cash Flow | – | -$11 | -$3 | -$2 |